Meet the 4 Artemis II astronauts who are getting ready for a flight to the far side of the moon

Artemis II will launch four astronauts on a 10-day crewed test flight around the far side of the moon atop NASA's 3.5-million-pound SLS rocket and Orion capsule, validating life‑support, crew controls and reentry profiles after Artemis I identified heat‑shield damage. NASA awarded a nearly $3 billion lunar lander contract to SpaceX in 2021, but Starship's earlier failures, complex in‑space refueling requirements (ten+ tanker launches) and program delays have pushed a targeted surface return to 2028; NASA is pressing contractors and seeking backup lander approaches while private competitors like Blue Origin pivot resources toward lunar landers and pause other commercial flights.

Analysis

Market structure: Artemis II reinforces a bifurcated space market — legacy prime contractors (Lockheed Martin, Northrop Grumman, Boeing) capture near-term NASA cash for Orion/SLS work while reusable players (SpaceX, Blue Origin paradigms) threaten long-term pricing power. SLS at >$2bn/launch is structurally uncompetitive vs. reusable marginal-cost targets (orders of magnitude lower), implying downward pressure on per-launch pricing and upward pressure on commercial launch volumes over 3–7 years. Expect suppliers of cryogenic propellant, avionics and rendezvous technologies to see rising demand; launch manifest growth boosts satellite and materials demand modestly but not enough to move commodities globally.

Risk assessment: Immediate tail risks include a catastrophic Artemis II failure (days) that would trigger program pauses, insurance cost spikes and a short-term selloff in contractor stocks (~-10–25%). Short-term (weeks–months) risks center on SpaceX Starship refueling tests and Congressional funding decisions; long-term (years) risks are geopolitical (China lunar first-mover) prompting accelerated defense budgets or procurement shifts. Hidden dependencies: NASA’s timeline hinges on multi-launch in-orbit refueling (10+ tanker missions) and appropriations; schedule slippage is the baseline.

Trade implications: Event-driven trades: asymmetric long exposure to established primes and optionality on commercial launch specialists. Tactical options play: buy 3–6 month call spreads on LMT/NOC to capture positive mission headlines; hedge execution risk with 6–12 month put spreads on BA. Rotate into RKLB as a 1–2% option-like growth stake if reusable logistics demonstrators show progress in next 6–12 months. Use tight stops (6–10%) around mission dates.

Key Decisions for Investors

• Establish a 2–3% portfolio long in LMT (Lockheed Martin) via a 3–6 month call spread (buy 5–10% OTM call, sell 10–15% OTM call) to capture near-term NASA contract upside; use a 8% stop on underlying exposure and trim 50% within 5 trading days after a successful Artemis II.
• Add a 1–2% outright long position in NOC (Northrop Grumman) with a 3–12 month horizon to benefit from SLS/lander subcontracting; increase allocation by 1% on positive Artemis II outcome within 7 days, or cut to zero if shares fall >12% on mission-related news.
• Initiate a tactical 0.5–1% short via a 6–12 month put spread on BA (Boeing) to hedge program execution and political risk from SLS cost scrutiny (e.g., buy 12% OTM put, sell 20% OTM put); close or reassess if BA trades >+15% on broader market moves.
• Allocate 1–2% to RKLB (Rocket Lab) equity as asymmetric long optionality on commercial lunar/logistics demand; add a second tranche (another 1–2%) only after either a successful Starship in-orbit refuel demo or Blue Origin New Glenn/Mark1 lunar lander success within 6–12 months.
• Trigger-based monitoring: within 60–120 days watch for FY NASA appropriations language and within 12 months watch for a successful Starship in-orbit refueling test; if both clear, rotate 50% of prime-contractor gains into reusable-launch specialists (RKLB/selected commercial names).